Research on stem cell therapy has shown promise as a therapy for multiple sclerosis. Which type of stem cells do you think shows the most promise for patients with advanced multiple sclerosis?
It is sometimes challenging to capture multiple sclerosis disease activity and, therefore, to track the efficacy of interventions. Do you think current measures are relevant for assessing intervention...
Do you know which vaccine is NOT recommended for patients with multiple sclerosis who are initiating immunotherapy? Test your knowledge with our latest pop quiz!
How well do you know the AAN's guidance on Vaccine-Preventable Infections and Immunization in Multiple Sclerosis? Test your knowledge with our latest pop quiz!
Clinically isolated syndrome (CIS) is a first episode of neurologic symptoms that lasts at least 24 hours and is caused by inflammation or demyelination in the central nervous system. Do you think testing...
The AAN recommends the use of cannabis among patients with selected neurologic disorders. Do you know whether the AAN recommends oral cannabis extract for reducing symptoms of multiple sclerosis?
The American Academy of Neurology guidelines offer several recommendations on starting disease-modifying therapy for patients with multiple sclerosis. Do you know whether the guidelines recommend the...
The American Academy of Neurology guidelines offer several recommendations on starting disease-modifying therapy for patients with multiple sclerosis. Do you know whether the guidelines recommend the...
Are you familiar with the American Academy of Neurology’s guidelines on seasonal influenza vaccinations among individuals with multiple sclerosis? Find out by taking our pop quiz.
When relapsing-remitting multiple sclerosis worsens to secondary progressive multiple sclerosis, do you think disease-modifying therapies should be stopped? Let us know your opinion with our latest poll. ...
